A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
about
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
description
scientific article published on 01 July 2019
@en
name
A Proof-of-Concept Study Evalu ...... lled Symptoms of Schizophrenia
@en
type
label
A Proof-of-Concept Study Evalu ...... lled Symptoms of Schizophrenia
@en
prefLabel
A Proof-of-Concept Study Evalu ...... lled Symptoms of Schizophrenia
@en
P2093
P1476
A Proof-of-Concept Study Evalu ...... lled Symptoms of Schizophrenia
@en
P2093
Adam Ogden
Christopher J Schmidt
David P Walling
Eve H Pickering
Lev Gertsik
Rene N Lopez
P304
P356
10.1097/JCP.0000000000001047
P577
2019-07-01T00:00:00Z